Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO ...

Parkinson’s disease is a neurodegenerative disorder that causes a gradual loss of brain nerve cells, which produce a chemical messenger called dopamine. Dopamine relays signals throughout the brain ...

As it continues to ramp up sales of its attention-deficit/hyperactivity disorder (ADHD) drug Qelbree, Supernus Pharmaceuticals is getting Busy to raise awareness of ...

May 20, 2025 (GLOBE NEWSWIRE) -- Actress, author, podcaster, and mom, Busy Philipps, is stepping into an important new role as 'Ms. Represented' in partnership with Supernus Pharmaceuticals for a new ...

Busy Philipps partners with Supernus Pharmaceuticals to launch a campaign addressing ADHD in women, sharing her personal journey with Qelbree. Actress Busy Philipps has partnered with Supernus ...

Short interest in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) decreased during the last reporting period, falling from 4.14M to 3.97M. This put 10.76% of the company's publicly available shares short.

Opinions expressed are those of the author. Membership (fee-based) Judit Sharon is the founder and CEO of OnPage Corporation, an advanced, secure critical communication and collaboration platform ...

President and CEO of Supernus. “In addition, we are pleased to be bringing ONAPGO to market, another growth driver for our business. ONAPGO represents a novel approach for adults with Parkinson ...